Addus HomeCare Market Cap 2012-2025 | ADUS

Addus HomeCare market cap history and chart from 2012 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Addus HomeCare market cap as of March 06, 2026 is $2.1B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.103B $1.155B
ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company's services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $34.042B 17.17
Quest Diagnostics (DGX) United States $23.013B 21.00
Elanco Animal Health (ELAN) United States $12.486B 26.18
Encompass Health (EHC) United States $11.082B 20.17
DaVita (DVA) United States $9.950B 13.72
Chemed (CHE) United States $6.703B 23.54
Option Care Health (OPCH) United States $5.622B 23.93
RadNet (RDNT) United States $5.365B 183.00
LifeStance Health (LFST) United States $2.735B 0.00
Aveanna Healthcare Holdings (AVAH) United States $1.657B 20.87
U.S Physical Therapy (USPH) United States $1.322B 33.44
Pennant (PNTG) United States $1.106B 36.75
Astrana Health (ASTH) United States $1.057B 98.84
Daxor (DXR) United States $0.062B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.038B 0.00
Psychemedics (PMD) United States $0.000B 0.00